Latest Avidity Biosciences News & Updates

See the latest news and media coverage for Avidity Biosciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Avidity Biosciences

Biotechnology company developing targeted RNA therapeutics

aviditybiosciences.com
Headquarters
San Diego, United States
Company type
Private company
Number of employees
400–500
Industry
Pharmaceuticals

Last updated

Latest news about Avidity Biosciences

In short: Avidity Biosciences was acquired by Novartis for $12 billion after reporting positive clinical data and strong third-quarter earnings.

Company announcements

Avidity Biosciences

Avidity Biosciences enters a definitive merger agreement with Novartis

Novartis gains the neuroscience pipeline and RNA platform, while Avidity’s cardiology division spins off into a new public entity.

Unlock all announcements with a

Media coverage

PR Newswire

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to separate its early-stage precision...

Unlock all articles with a

Never miss news about Avidity Biosciences

Track Avidity Biosciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Avidity Biosciences competitors & trending companies

Browse news for competitors to Avidity Biosciences and other trending companies.